Coleman Mark 4
4 · Axsome Therapeutics, Inc. · Filed Feb 25, 2026
Insider Transaction Report
Form 4
Coleman Mark
Director
Transactions
- Exercise/Conversion
Common Stock
[F1]2026-02-23$4.95/sh+6,250$30,938→ 72,140 total - Exercise/Conversion
Stock Option (Right to Buy)
[F1]2026-02-23−6,250→ 7,721 totalExercise: $4.95From: 2018-03-15Exp: 2027-03-15→ Common Stock (6,250 underlying)
Holdings
- 403,856(indirect: See Footnote)
Common Stock
[F2]
Footnotes (2)
- [F1]Represents the exercise of stock options, prior to the 10-year expiration date, for cash and hold of underlying shares.
- [F2]Such shares are held by an entity, of which the reporting person has voting and dispositive power, and therefore, the reporting person is deemed to be the indirect beneficial owner of such shares.
Signature
/s/ Nick Pizzie, Attorney-in-Fact|2026-02-25